Technical Analysis for SCPH - scPharmaceuticals Inc.

Grade Last Price % Change Price Change
grade A 6.3206 -0.62% -0.04
SCPH closed down 0.62 percent on Friday, August 23, 2019, on 21 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical SCPH trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week High Strength -0.62%
Upper Bollinger Band Walk Strength -0.62%
Outside Day Range Expansion -0.62%
Overbought Stochastic Strength -0.62%

Older signals for SCPH ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ScPharmaceuticals, Inc. is a United States-based biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The sc2Wear Infusor includes features, such as two-component design, automated safety features and micropiston pump technology. Its pipeline includes product timelines for preclinical, through regulatory approval. Its products will be administered subcutaneously through the sc2Wear Infusor. Its lead products are subcutaneous formulations of furosemide (parenteral diuretic in treating heart failure) and ceftriaxone (parenteral antibiotic outside the hospital setting). Its furosemide formulation has been optimized for use with the sc2Wear Infusor. Its pipeline also includes Ertapenem for subcutaneous delivery.
Medicine Biopharmaceutical Drugs Chemical Compounds Medication Pharmaceutical Products Dosage Forms Heart Failure Chloroarenes Injection Intravenous Therapy
Is SCPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.719
52 Week Low 2.44
Average Volume 74,219
200-Day Moving Average 3.9241
50-Day Moving Average 4.6712
20-Day Moving Average 5.8545
10-Day Moving Average 6.1181
Average True Range 0.5279
ADX 35.87
+DI 23.7025
-DI 11.7302
Chandelier Exit (Long, 3 ATRs ) 5.1353
Chandelier Exit (Short, 3 ATRs ) 6.6337
Upper Bollinger Band 6.6134
Lower Bollinger Band 5.0956
Percent B (%b) 0.81
BandWidth 25.925357
MACD Line 0.4461
MACD Signal Line 0.4514
MACD Histogram -0.0053
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.03
Resistance 3 (R3) 7.06 6.87 6.91
Resistance 2 (R2) 6.87 6.69 6.85 6.87
Resistance 1 (R1) 6.59 6.58 6.50 6.56 6.83
Pivot Point 6.40 6.40 6.35 6.38 6.40
Support 1 (S1) 6.12 6.22 6.03 6.09 5.81
Support 2 (S2) 5.93 6.11 5.91 5.77
Support 3 (S3) 5.65 5.93 5.73
Support 4 (S4) 5.62